文献速递传染病防控与疫情报告妇幼与学校卫生

苏格兰呼吸道哨点监测中肺炎支原体流行病学及合并其他呼吸道病原体检出情况(2022年10月至2025年5月)

Epidemiology of Mycoplasma pneumoniae and co-detection with other respiratory pathogens in a respiratory sentinel surveillance system in Scotland, October 2022 to May 2025.
PubMed 文献 · Euro Surveill · 2026-01-01

基于苏格兰呼吸道哨点监测系统,对65,798例急性呼吸道感染患者的上呼吸道拭子检测10种呼吸道病原体,其中3,031例(4.6%)肺炎支原体阳性,2023年10月至2024年10月阳性率升高,5-14岁儿童尤为明显,2024年第1周峰值达47.7%(31/65)。在可行全病原检测的支原体阳性病例中,26.0%(728/2,799)合并其他病原体检出,0-4岁合并率61.3%(122/199),5-14岁31.3%(321/1,024),以鼻病毒合并为主(47.5%;346/728)。3,031例中1.8%(55例)在检测阳性后14天内住院。

要点

  • 2023年10月至2024年10月肺炎支原体阳性率升高,5-14岁儿童尤为突出,2024年第1周峰值47.7%。
  • 支原体阳性者中26.0%合并其他呼吸道病原体,0-4岁合并率高达61.3%,以鼻病毒为主。
  • 社区哨点监测可刻画支原体流行特征,≤14岁儿童合并检出常见,与住院儿科报道一致。

核心结论

  • 社区呼吸道哨点监测有助于刻画肺炎支原体流行,并揭示≤14岁儿童中呼吸道病原体合并检出频繁,与既往住院儿科支原体病例报道一致。

研究设计与样本

  • 基于苏格兰呼吸道哨点监测系统,纳入2022年10月至2025年5月因急性呼吸道感染就诊于全科医生的代表性社区样本65,798例,采集上呼吸道拭子检测10种呼吸道病原体(含肺炎支原体)。
  • 对肺炎支原体阳性率进行时间趋势监测,评估单一或多种病原体联合检出情况并按人口学特征分层,同时统计支原体阳性检测后14天内住院比例。

主要发现

  • 65,798例患者中(女40,158例、男25,534例、性别未知106例;中位年龄35岁,IQR 17-59),3,031例(4.6%)肺炎支原体阳性(女1,686例、男1,340例、性别未知5例;中位年龄18岁,IQR 9-39)。
  • 肺炎支原体阳性率在2023年10月至2024年10月升高,尤其5-14岁年龄组,2024年第1周峰值达47.7%(31/65)。
  • 在可行全病原检测的支原体阳性病例中,26.0%(728/2,799)合并检出另一种病原体,0-4岁合并率61.3%(122/199),5-14岁31.3%(321/1,024)。
  • 合并检出以鼻病毒为主(47.5%;346/728),其余合并病原体随病原体和年龄而异。
  • 3,031例肺炎支原体病例中,1.8%(55例)在检测阳性后14天内住院。

临床怎么用

  • 在社区急性呼吸道感染监测中,应关注肺炎支原体流行趋势,尤其5-14岁儿童阳性率升高时。
  • 对≤14岁儿童支原体阳性者,需考虑合并其他呼吸道病原体(如鼻病毒)的可能,结合临床综合判断。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUNDCommunity-acquired pneumonia by Mycoplasma pneumoniae is often complicated by co-infections with other respiratory pathogens.AIMWe describe through a sentinel respiratory surveillance system in Scotland, M. pneumoniae infection occurrence in patients presenting to general practitioners with acute respiratory infection (ARI) (October 2022-May 2025) and the co-detection frequency of other respiratory pathogens.METHODSUpper respiratory tract swabs from a representative community sample of 65,798 ARI patients were laboratory-tested for 10 respiratory pathogens, including M. pneumoniae. Positivity for M. pneumoniae was monitored over time. Single or multiple joint pathogen detections were assessed and stratified by demographic characteristics. Proportions hospitalised within 14 days after their M. pneumoniae positive test were determined.RESULTSOf 65,798 patients (40,158 female, 25,534 male, 106 sex unknown; median age: 35 years, interquartile range (IQR): 17-59), 3,031 (4.6%) were M. pneumoniae positive (1,686 female, 1,340 male, five sex unknown; median age: 18 years, IQR: 9-39). Positivity was elevated in October 2023-October 2024, particularly in 5-14-year-olds, and peaked at 47.7% (31/65) in week 1, 2024. Among M. pneumoniae cases viably tested for all pathogens, 26.0% (728/2,799) had co-detections of another pathogen, with rates in 0-4-year-olds (61.3%; 122/199) and 5-14-year-olds (31.3%, 321/1,024) reflecting those reported elsewhere in hospitalised paediatric cases. Co-detections involving rhinovirus (47.5%; 346/728) predominated, otherwise varying by pathogen and age. Of 3,031 M. pneumoniae cases, 1.8% (n = 55) were admitted.CONCLUSIONSentinel surveillance of respiratory pathogens in the community was helpful to characterise an M. pneumoniae epidemic, revealing frequent respiratory-pathogen co-detections in ≤ 14-year-olds, as prior reported in hospitalised M. pneumoniae paediatric cases.

来源:Euro Surveill,查看原文。版权归原作者所有。

引用

  1. Gadegaard H, Hamilton M, Oliver C, et al. Epidemiology of Mycoplasma pneumoniae and co-detection with other respiratory pathogens in a respiratory sentinel surveillance system in Scotland, October 2022 to May 2025. Euro Surveill. 2026. PMID: 42495765. doi:10.2807/1560-7917.ES.2026.31.29.2500845

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。